Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
ST5 was identified by its ability to suppress the tumorigenicity of Hela cells in nude mice. Zusätzlich bieten wir Ihnen Suppression of Tumorigenicity 5 Proteine (3) und Suppression of Tumorigenicity 5 Kits (1) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 53 products:
DENND2B interacts with the Rab13 (zeige RAB13 Antikörper) effector MICAL-L2 (zeige MICALL2 Antikörper) at the cell periphery, and this interaction is required for the dynamic remodeling of the cell's leading edge.
Using RNA in situ hybridisation in mouse, the authors found that St5 is expressed in the frontal cortex during embryonic development. In adult mouse brain, expression of St5 was especially high in the hippocampal area and cerebellum.
This gene was identified by its ability to suppress the tumorigenicity of Hela cells in nude mice. The protein encoded by this gene contains a C-terminal region that shares similarity with the Rab 3 family of small GTP binding proteins. This protein preferentially binds to the SH3 domain of c-Abl kinase, and acts as a regulator of MAPK1/ERK2 kinase, which may contribute to its ability to reduce the tumorigenic phenotype in cells. Three alternatively spliced transcript variants of this gene encoding distinct isoforms are identified.
suppression of tumorigenicity 5
, suppression of tumorigenicity 5 protein
, DENN/MADD domain containing 2B
, heLa tumor suppression 1
, DENN domain-containing protein 2B